Differential Protein Expression in Congenital and Acquired Cholesteatomas.

Furthermore, the roles of intracellular TrxR activity, TrxR1 and Trx protein expression levels in cell apoptosis, were also investigated, and the results showed that the cellular

Tabela 23 – Teste de normalidade para a Perceção de eficácia da dieta na prevenção de doenças e a Utilização das alegações média .... 54 Tabela 32 – Teste de normalidade

Epidermis Growth Factor (EGF) and its receptor (EGF- R) were studied in acquired cholesteatoma by many authors that agreed in their findings regarding the immunoexpression of EGF-R

(A) protein expression normalized by ACTB and calibrated by the level of a reference sample; (B) the ratio of NPM1 protein expression between tumor and matched non-neoplastic

With the increase of matrine concentration, the relative expression level of Bcl-2 protein in CNE-2 cells was decreased, and the expression level of Caspase-3 protein was

In accordance with data presented in drug screening, AK-4 compound C39H50O5Si2 displayed strong cytotoxic capability against the growth of two glioblastoma cell lines LN229 and SNB19

In 1953, House 1 was the first to describe a cholesteatoma behind an intact membrane while in 1991, Proctor 2 reported that congenital cholesteatoma originated from the

We found that PTEN and E-cadherin protein expression level was downregulated while β -catenin, cJUN, MMP-2 and N-cadherin protein expression levels were upregulated when

Differential expression analysis showed that 25 conserved and 21 novel miRNAs were differentially expressed between epiphyllous ovule leaves and normal leaves.. The expression